Insulet
PODD
134.36
-0.37
-0.27%
Insulet
US · PODD
#1561 by market cap
Listed 1970
134.36
-0.37
-0.27%
Live - 5344 symbols - heartbeat 354s ago
· 2026-10-08 07:58
Pre-market
134.36
0.00%
After-hours
134.36
0.00%
- Market cap
- 9.32B
- P/E (TTM)i
- 25.21
- P/Bi
- 6.55
- EPSi
- 3.48
- Div yieldi
- 0.00%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on PODD?
Anonymous reader poll. Unscientific, not investment advice.
About Insulet
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.
- Founded
- 2000
- CEO
- Ms. Ashley A. McEvoy
- Employees
- 5,400
- Headquarters
- Acton, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- insulet.com
Company profile
- Exchange
- US
- Symbol
- PODD
- Market-cap rank
- #1561
- Listing date
- 1970-01-01
- Market cap
- 9.32B
- Float cap
- 9.28B
- Shares out
- 69.35M
- Float shares
- 69.06M
Sectors & themes
Medical Devices
Global medical industry
Fractional Shares JP
Quote time 2026-10-08 07:58:22 · For reference only, not investment advice and not tailored to your situation.